Often, the decision to stop stems from a lack of clear physiological markers of improvement
A detailed semaglutide vs tirzepatide comparison covers the broader differences between these medications, and the side effect comparison is particularly relevant for endometriosis patients weighing options
Despite its advantages, its important to acknowledge GHK-Cus limitations when compared to traditional acne treatments in a research context: Limited Direct Evidence for Active Acne Vulgaris: While it has anti-inflammatory properties, there is currently limited direct clinical evidence specifically demonstrating GHK-Cu as a primary treatment for active acne breakouts (e.g., reducing papules, pustules, or cysts)
Competitive athletes should avoid it entirely unless willing to accept the consequences of a possible drug test failure
It has not undergone Phase I, II, or III human clinical trials and is not recognized as Generally Recognized as Safe (GRAS)
Better recovery between workouts becomes noticeable by weeks two through four
